- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Our experience with 134 patients who started allergen immunotherapy during the past two years at Nippon Medical School Hospital
-
- HARAGUCHI Mihoko
- Department of Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School Hospital
-
- GOTOH Minoru
- Department of Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School Hospital
-
- WAKAYAMA Nozomu
- Department of Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School Hospital
-
- YOSHINO Ayaho
- Department of Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School Hospital
-
- MURAKAMI Ryosuke
- Department of Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School Hospital
-
- KUSAMA Kaoru
- Department of Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School Hospital
-
- OKUBO Kimihiro
- Department of Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School Hospital
Bibliographic Information
- Other Title
-
- 当科アレルギー外来において過去 2 年間にアレルゲン免疫療法を開始した患者の現況
Search this article
Description
A clinical study of 134 patients (65 males, 69 females) who started allergen immunotherapy in the Department of Otorhinolaryngology at Nippon Medical School Hospital between April 2010 and May 2012 was performed. We examined the age distribution, the initial and maintenance doses, the number of injections, the rate and the details of side effects, the number of patients who discontinued treatment, and the number of days that the patients took medication. There are 69 patients (51.5%) aged 30 to 49 years and 18 patients (13.4%) aged three to 14 years. There was a wider range of initial and maintenance doses for patients receiving Japanese cedar immunotherapy than for those with allergies to house dust. Five patients experienced a side effect during immunotherapy, but there were no fatalities. Twenty-two patients (16.4%) discontinued immunotherapy. Twenty-eight percent of the patients who received cedar immunotherapy did not need to take medication during the cedar season in 2012.
Journal
-
- jibi to rinsho
-
jibi to rinsho 59 (3), 93-100, 2013-05-20
JIBI TO RINSHO KAI
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679548950400
-
- NII Article ID
- 130004555607
-
- ISSN
- 21851034
- 04477227
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed